In AML cells, IL1RAP physically interacts with c-kit and FLT3, inducing FLT3 phosphorylation and maintaining cellular proliferation, making it an attractive target for chemotherapeutic intervention. This evidence concerns the gene KIT and acute myeloid leukemia.